Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the
center of Alzheimer's disease (AD) pathophysiology. While the detailed molecular …

COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

Background Diabetes has been associated with increased COVID-19-related mortality, but
the association between modifiable risk factors, including hyperglycaemia and obesity, and …

Background Although diabetes has been associated with COVID-19-related mortality, the
absolute and relative risks for type 1 and type 2 diabetes are unknown. We assessed the …

Methods We conducted a nationwide multicentre observational study in people with
diabetes hospitalised for COVID-19 in 53 French centres in the period 10–31 March 2020 …

Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature
hyperinflammation, and the associated biomarkers may be beneficial for risk stratification …

Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …

Objective Clinical and laboratory biomarkers to predict the severity of coronavirus disease
2019 (COVID-19) are essential in this pandemic situation of which resource allocation must …

Background There is growing evidence that patients recovering after a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have a variety of acute …

Background The aim of this study is to evaluate the impact of diabetes, hypertension,
cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin …